Single-chain variable fragments, diabodies and chimeric antibodies (mouse variable domains and human immunoglobulin constant domains) were engineered by DNA recombinant technique and expressed transiently in tobacco leaves. The plants expressed the three types of antigen-binding moieties, accurately and faithfully. The yield obtained was 32 mg, 40 mg and 20 mg respectively, per kg of wet weight of leaves. The chimeric antibody had high affinity for human chorionic gonadotropin (Ka=1.9×1010M−1). All three forms of the recombinant antibodies expressed by plants inhibited the binding of hCG to receptor on Leydig cells
BACKGROUND: Antibodies for human clinical applications are predominantly produced in mammalian expre...
Rhizosecretion of recombinant pharmaceuticals from in vitro hydroponic transgenic plant cultures is ...
EDITORIAL The infectious diseases are commonly caused by disease-causing microorganisms and it may l...
Single-chain variable fragments, diabodies and chimeric antibodies (mouse variable domains and human...
Background: Antibody engineering facilitates the construction of different antibody formats [single ...
The plant-based production of biopharmaceuticals has attracted interest because plants, compared to ...
The aims of this work were to obtain a human antibody against the tumour-associated antigen tenascin...
To evaluate the expression of different forms of a tumor-specific antibody in plants, we adapted a r...
Antibodies represent a large proportion of therapeutic drugs currently in development. In most cases...
Antibodies (Abs) can be selected for specific binding to an almost limitless array of targets, inclu...
Leutinising hormone releasing hormone (LHRH) is a hypothalamic neurohormone that plays a pivotal rol...
Problem: A recombinant chimeric antibody against hCG (cPIPP) has been engineered and expressed at hi...
AbstractThe use of transgenic plants as a production system for recombinant subunit vaccines has bee...
Problem: Prototype human chorionic gonadotropin (hCG) vaccines based on natural sources are unsuitab...
Functional VHH single domain antibody lacking light chains occur naturally in Camelidae. The single ...
BACKGROUND: Antibodies for human clinical applications are predominantly produced in mammalian expre...
Rhizosecretion of recombinant pharmaceuticals from in vitro hydroponic transgenic plant cultures is ...
EDITORIAL The infectious diseases are commonly caused by disease-causing microorganisms and it may l...
Single-chain variable fragments, diabodies and chimeric antibodies (mouse variable domains and human...
Background: Antibody engineering facilitates the construction of different antibody formats [single ...
The plant-based production of biopharmaceuticals has attracted interest because plants, compared to ...
The aims of this work were to obtain a human antibody against the tumour-associated antigen tenascin...
To evaluate the expression of different forms of a tumor-specific antibody in plants, we adapted a r...
Antibodies represent a large proportion of therapeutic drugs currently in development. In most cases...
Antibodies (Abs) can be selected for specific binding to an almost limitless array of targets, inclu...
Leutinising hormone releasing hormone (LHRH) is a hypothalamic neurohormone that plays a pivotal rol...
Problem: A recombinant chimeric antibody against hCG (cPIPP) has been engineered and expressed at hi...
AbstractThe use of transgenic plants as a production system for recombinant subunit vaccines has bee...
Problem: Prototype human chorionic gonadotropin (hCG) vaccines based on natural sources are unsuitab...
Functional VHH single domain antibody lacking light chains occur naturally in Camelidae. The single ...
BACKGROUND: Antibodies for human clinical applications are predominantly produced in mammalian expre...
Rhizosecretion of recombinant pharmaceuticals from in vitro hydroponic transgenic plant cultures is ...
EDITORIAL The infectious diseases are commonly caused by disease-causing microorganisms and it may l...